Merck KGaA (FRA:MRK) has been given a €105.00 ($123.53) target price by research analysts at Independent Research GmbH in a research report issued to clients and investors on Monday. The firm presently has a “neutral” rating on the healthcare company’s stock.

Several other research firms also recently weighed in on MRK. S&P Global set a €115.00 ($135.29) price target on shares of Merck KGaA and gave the stock a “neutral” rating in a research report on Friday, May 19th. Nord/LB set a €114.00 ($134.12) price target on shares of Merck KGaA and gave the stock a “neutral” rating in a research report on Friday, May 19th. Commerzbank Ag set a €109.00 ($128.24) price target on shares of Merck KGaA and gave the stock a “neutral” rating in a research report on Friday, May 19th. J P Morgan Chase & Co restated a “neutral” rating on shares of Merck KGaA in a research report on Friday, May 19th. Finally, Goldman Sachs Group, Inc. (The) set a €110.00 ($129.41) price target on shares of Merck KGaA and gave the stock a “neutral” rating in a research report on Friday, May 19th. Sixteen equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average price target of €108.00 ($127.06).

Merck KGaA (FRA:MRK) opened at 92.00 on Monday. Merck KGaA has a 12-month low of €89.00 and a 12-month high of €115.00. The stock has a market capitalization of €40.00 billion and a PE ratio of 23.98. The stock has a 50 day moving average price of €95.91 and a 200-day moving average price of €103.18.

ILLEGAL ACTIVITY WARNING: This piece of content was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece of content on another domain, it was illegally copied and republished in violation of U.S. and international trademark & copyright law. The legal version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/08/28/merck-kgaa-mrk-pt-set-at-105-00-by-independent-research-gmbh.html.

About Merck KGaA

.

Analyst Recommendations for Merck KGaA (FRA:MRK)

Receive News & Stock Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related stocks with our FREE daily email newsletter.